|
Volumn 55, Issue 3, 2002, Pages 177-181
|
Limitations of the use of single base changes in the p53 gene to detect minimal residual disease of breast cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DNA BASE;
GENE PRODUCT;
PROTEIN P53;
ARTICLE;
BREAST CANCER;
CANCER RECURRENCE;
CANCER STAGING;
CELL TRANSPLANTATION;
CLINICAL PRACTICE;
CONTROLLED STUDY;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC VALUE;
DISEASE MODEL;
DNA SCREENING;
FEMALE;
GEL ELECTROPHORESIS;
GENE AMPLIFICATION;
GENE MUTATION;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MAJOR CLINICAL STUDY;
POINT MUTATION;
PRIORITY JOURNAL;
PROTEIN DENATURATION;
SENSITIVITY AND SPECIFICITY;
STEM CELL;
TUMOR SUPPRESSOR GENE;
BREAST NEOPLASMS;
DNA MUTATIONAL ANALYSIS;
DNA, NEOPLASM;
FEASIBILITY STUDIES;
FEMALE;
GENES, P53;
GENETIC MARKERS;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HEMATOPOIETIC STEM CELLS;
HUMANS;
MUTATION;
NEOPLASM CIRCULATING CELLS;
NEOPLASM, RESIDUAL;
POINT MUTATION;
|
EID: 0036276804
PISSN: 13668714
EISSN: None
Source Type: Journal
DOI: 10.1136/mp.55.3.177 Document Type: Article |
Times cited : (9)
|
References (34)
|